Literature DB >> 19409021

Embryopathogenetic surgicoanatomical classification of dysraphism and surgical outcome of spinal lipoma: a nationwide multicenter cooperative study in Japan.

Shizuo Oi1, Sadahiro Nomura, Masato Nagasaka, Hajime Arai, Reizo Shirane, Yasuo Yamanouchi, Hiroshi Nishimoto, Hiroaki Date.   

Abstract

OBJECT: The natural history of asymptomatic spinal lipoma in infancy remains unclear, and the indication for the prophylactic untethering operation is still debatable. To address this question, a multicenter cooperative study for the treatment of spinal lipoma was performed by the 7 most active institutions in neurosurgical care for spina bifida in Japan between 2001 and 2005.
METHODS: Patients were classified using the embryopathogenetic surgicoanatomical classification. Their neurosurgical postoperative course was analyzed using the Spina Bifida Neurological Scale. Among 261 patients, 159 were asymptomatic and 102 were symptomatic.
RESULTS: Of the 136 patients for whom prophylactic surgeries were performed, 135 remained asymptomatic and only 1 (0.4%) of the 261 patients presented with mild sensory disturbance. Mild foot deformity was identified in 1 (4.3%) of 23 conservatively observed patients. Of 100 symptomatic patients, deterioration after surgery was seen in 6%, and improvement in 44%. Complete resolution of symptoms was seen in only 14.2%. Filar types for patients > 3 years old improved in Spina Bifida Neurological Scale scores from 12.3 to 14.0. The mean age of symptomatic patients with lipomyelomeningocele was the youngest of all (1.3 years), which indicates lipomyelomeningocele may deteriorate in early infancy. Improvements from surgery were seen for all types of lipoma except the caudal type, presenting at an older mean age (15 years).
CONCLUSIONS: A low rate of postsurgical worsening indicates that surgeries for asymptomatic and symptomatic lipomas are safe. Surgeries done after the onset of symptoms seldom cure the patients. These two results support early untethering for any kind of lipoma; however, further study of the natural history is required.

Entities:  

Mesh:

Year:  2009        PMID: 19409021     DOI: 10.3171/2009.1.PEDS08168

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  5 in total

Review 1.  Conservative and surgical treatment of pediatric asymptomatic lumbosacral lipoma: a meta-analysis.

Authors:  Yang Xiong; Liu Yang; Wang Zhen; Dong Fangyong; Wan Feng; Lei Ting
Journal:  Neurosurg Rev       Date:  2016-10-28       Impact factor: 3.042

Review 2.  Lack of uniformity in the clinical assessment of children with lipomyelomeningocele: a review of the literature and recommendations for the future.

Authors:  Lindy May; Richard Hayward; Aabir Chakraborty; Linda Franck; Grazia Manzotti; Jo Wray; Dominic Thompson
Journal:  Childs Nerv Syst       Date:  2013-03-20       Impact factor: 1.475

Review 3.  Acute presentations of intradural lipomas: case reports and a review of the literature.

Authors:  Luca Massimi; Thailane Maria Feitosa Chaves; François Yves Legninda Sop; Paolo Frassanito; Gianpiero Tamburrini; Massimo Caldarelli
Journal:  BMC Neurol       Date:  2019-08-08       Impact factor: 2.474

4.  A systematic review and meta-analysis of minimally invasive surgery in children with occult tethered cord syndrome.

Authors:  Ketao Xu; Jianhua He; Leibo Wang
Journal:  Transl Pediatr       Date:  2022-03

5.  The Japan Neurosurgical Database: Statistics Update 2018 and 2019.

Authors:  Koji Iihara; Nobuhito Saito; Michiyasu Suzuki; Isao Date; Yukihiko Fujii; Kiyohiro Houkin; Tooru Inoue; Toru Iwama; Takakazu Kawamata; Phyo Kim; Hiroyuki Kinouchi; Haruhiko Kishima; Eiji Kohmura; Kaoru Kurisu; Keisuke Maruyama; Yuji Matsumaru; Nobuhiro Mikuni; Susumu Miyamoto; Akio Morita; Hiroyuki Nakase; Yoshitaka Narita; Ryo Nishikawa; Kazuhiko Nozaki; Kuniaki Ogasawara; Kenji Ohata; Nobuyuki Sakai; Hiroaki Sakamoto; Yoshiaki Shiokawa; Jun C Takahashi; Keisuke Ueki; Toshihiko Wakabayashi; Koji Yoshimoto; Hajime Arai; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-11-03       Impact factor: 1.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.